Idera Pharmaceuticals, Inc. (IDRA) Narrows Q4 Loss to 24c/Share

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q4 EPS of ($0.24), versus ($0.35) reported last year.

For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• Morgan Stanley Upgrades Mitsubishi Chemical Holdings (4188:JP) (MTLHY) to Overweight